Literature DB >> 3032609

A luminescence Western blot with enhanced sensitivity for antibodies to human immunodeficiency virus.

R Schneppenheim, P Rautenberg.   

Abstract

A luminescence assay was adapted for detection of peroxidase-labelled secondary antibodies, which react specifically with antibodies to human immunodeficiency virus on Western blots. This method is about one hundred times more sensitive than either commercial enzyme-linked immunosorbent assay or the chromogenic peroxidase assay on Western blots and detects seroconversion earlier than any other technique currently available.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3032609     DOI： 10.1007/BF02097190

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


  8 in total

1.  Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISA.

Authors:  K O Habermehl; B Zorr; F Deinhardt; L Gürtler; M A Koch; G Maass; W Höpken; K W Knocke
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

2.  Luminescent visualization of antigens on blots.

Authors:  P Laing
Journal:  J Immunol Methods       Date:  1986-09-27       Impact factor: 2.303

3.  Enhanced luminescence enzyme immunoassay for factor VIII related antigen.

Authors:  H X Wang; J George; G H Thorpe; R A Stott; L J Kricka; T P Whitehead
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

4.  Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.

Authors:  S H Weiss; J J Goedert; M G Sarngadharan; A J Bodner; R C Gallo; W A Blattner
Journal:  JAMA       Date:  1985-01-11       Impact factor: 56.272

5.  Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

Authors:  J W Ward; A J Grindon; P M Feorino; C Schable; M Parvin; J R Allen
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

6.  HTLV-III in symptom-free seronegative persons.

Authors:  S Z Salahuddin; J E Groopman; P D Markham; M G Sarngadharan; R R Redfield; M F McLane; M Essex; A Sliski; R C Gallo
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

7.  Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.

Authors:  J E Groopman; P I Hartzband; L Shulman; S Z Salahuddin; M G Sarngadharan; M F McLane; M Essex; R Gallo
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

8.  Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus.

Authors:  H W Reesink; P N Lelie; J G Huisman; W Schaasberg; M Gonsalves; C Aaij; I N Winkel; J A van der Does; A C Hekker; J Desmyter
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321
  8 in total
  7 in total

1.  Localisation and functional studies on the 5'-nucleotidase of the cattle tick Boophilus microplus.

Authors:  N Liyou; S Hamilton; R Mckenna; C Elvin; P Willadsen
Journal:  Exp Appl Acarol       Date:  2000-03       Impact factor: 2.132

2.  Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus.

Authors:  N P Mahajan; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  MSY2 and MSY4 bind a conserved sequence in the 3' untranslated region of protamine 1 mRNA in vitro and in vivo.

Authors:  F Giorgini; H G Davies; R E Braun
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

4.  Structure of the yeast TAP1 protein: dependence of transcription activation on the DNA context of the target gene.

Authors:  T L Aldrich; G Di Segni; B L McConaughy; N J Keen; S Whelen; B D Hall
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  A testis cytoplasmic RNA-binding protein that has the properties of a translational repressor.

Authors:  K Lee; M A Fajardo; R E Braun
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  RecX protein abrogates ATP hydrolysis and strand exchange promoted by RecA: insights into negative regulation of homologous recombination.

Authors:  R Venkatesh; N Ganesh; N Guhan; M Sreedhar Reddy; T Chandrasekhar; K Muniyappa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

Review 7.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.